Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Butylphthalide for Cerebral Small Vessel Disease
NCT04078204Unknown
- Sponsor
- Peking Union Medical College Hospital
- Start
- Apr 2018
- Primary completion
- Feb 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised, double-blind trial in Cerebral Small Vessel Disease (CSVD) comparing Butylphthalide Soft Capsules with Placebo Soft Capsules (2 arms). Primary endpoints: Occurrence of the composite endpoint at 30 months, Change of CIBIC-Plus score at 30 months and 2 more. Status: unknown.
02
Drugs
butylphthalide
03
Conditions
Cerebral Small Vessel Disease (CSVD)
Beyond the preview
Go deeper on NCT04078204.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04078204.